KU Leuven-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2023

  1. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

    The European respiratory journal, Vol. 61, Núm. 1

  2. European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure, Vol. 25, Núm. 4, pp. 469-477

2022

  1. Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension

    Journal of Heart and Lung Transplantation, Vol. 41, Núm. 6, pp. 716-721

2021

  1. PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic

    Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1

  2. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

    Respiratory Medicine, Vol. 178

  3. Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry

    Respiratory Medicine, Vol. 177

2020

  1. Covid-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: A reference centre survey

    ERJ Open Research

2016

  1. Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology

    European Journal of Heart Failure, Vol. 18, Núm. 9, pp. 1119-1128

2014

  1. EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension

    American Heart Journal, Vol. 167, Núm. 2, pp. 210-217